Tumor necrosis factor receptor and Fas signaling mechanisms

Annual Review of Immunology

Volumn 17, Issue , 1999, Pages 331-367

  Wallach, D ^a   Varfolomeev, E E ^a   Malinin, N L ^a   Goltsev, Yuri V ^a   Kovalenko, A V ^a   Boldin, M P ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Apoptosis; Caspase; MAP kinase; NF B; Signaling

Indexed keywords

FAS ANTIGEN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

CYTOKINE PRODUCTION; ENZYME ACTIVATION; IMMUNE RESPONSE; LIGAND BINDING; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CASPASES; HUMANS; LIGANDS; LIPIDS; PHOSPHOLIPASES; PHOSPHORIC MONOESTER HYDROLASES; PROTEIN KINASES; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 0032969285     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.17.1.331     Document Type: Review

References (225)

1. Vandenabeele P, Declercq W, Beyaert R, Fiers W. 1995. Two tumor necrosis factor receptors: structure and function. Trends Cell Biol. 5:392-400
2. Ware CF, VanArsdale TL, Crowe PD, Browning JL. 1995. The ligands and receptors of the lymphotoxin system. Curr. Top. Microbiol. Immunol. 198:175-218
3. Wallach D. 1996. A decade of accumulated knowledge and emerging answers: the 6th International Congress on TNF Rhodes, Greece, May 1996. Eur. Cytokine Netw. 7:713-24
4. Darnay BG, Aggarwal BB. 1997. Early events in TNF signaling: a story of associations and dissociations. J. Leukocyte Biol. 61:559-66
5. Wallach D, Boldin M, Varfolomeev E, Beyaert R, Vandenabeele P, Fiers W. 1997. Cell death induction by receptors of the TNF family: towards a molecular understanding. FEBS Lett. 410:96-106
6. Nagata S. 1997. Apoptosis by death factor. Cell 88:355-65
7. Wallach D, Bigda J, Engelmann H. 1998. The TNF family and related molecules. In The Cytokine Network and Immune Functions, ed. J Théze, London/New York: Oxford Univ. Press. In press
8. Van Ostade X, Tavernier J, Fiers W. 1994. Structure-activity studies of human tumor necrosis factors. Protein Eng. 7:5-22
9. Williams Abbott L, Walter BN, Cheung TC, Goh CR, Porter AG, Ware CF. 1997. The lymphotoxin-alpha (LTalpha) subunit is essential for the assembly, but not for the receptor specificity, of the membrane-anchored LTalpha1beta2 heterotrimeric ligand. J. Biol. Chem. 272:19451-56
10. Montgomery RI, Warner MS, Lum BJ, Spear PG. 1996. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87:427-36
11. Mauri DN, Ebner R, Montgomery RI, Kochel KD, Cheung TC, Yu G-L, Ruben S, Murphy M, Eisenberg RJ, Cohen GH, Spear PG, Ware CF. 1998. LIGHT, a new member of the TNF superfamily, and lymphotoxin are ligands for herpesvirus entry mediator. Immunity 8:21-30
12. Rothe J, Lesslauer W, Lotscher H, Lang Y, Koebel P, Kontgen F, Althage A, Zinkernagel R, Steinmetz M, Bluethmann H. 1993. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798-802
13. Pfeffer K, Matsuyama T, Kundig TM, Wakeham A, Kishihara K, Shahinian A, Wiegmann K, Ohashi PS, Kronke M, Mak TW. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457-67
14. Erickson SL, de Sauvage FJ, Kikly K, Carver Moore K, Pitts Meek S, Gillett N, Sheehan KC, Schreiber RD, Goeddel DV, Moore MW. 1994. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 372:560-63
15. Rennert PD, James D, Mackay F, Browning JL, Hochmann PS. 1998. Lymph node genesis is induced by signaling through the lymphotoxin beta receptor. Immunity 9:71-79
16. Nagata S, Suda T. 1995. Fas and Fas ligand: lpr and gld mutations, Immunol. Today 16:39-43
17. Hernandez Caselles T, Stutman O. 1993. Immune functions of tumor necrosis factor. I. Tumor necrosis factor induces apoptosis of mouse thymocytes and can also stimulate or inhibit IL-6-induced proliferation depending on the concentration of mitogenic costimulation. J. Immunol. 151:3999-4012
18. Seino K, Kayagaki N, Okumura K, Yagita H. 1997. Antitumor effect of locally produced CD95 ligand. Nat. Med. 3:165-70
19. Grell M, Douni E, Wajant H, Löhden M, Clauss M, Baxciner B, Georgopoulos S, Lesslauer W, Kollias G, Pfizenmaier K, Scheurich P. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83:793-802
20. Mackay F, Majeau GR, Hochman PS, Browning JL. 1996. Lymphotoxin beta receptor triggering induces activation of the nuclear factor kappa B transcription factor in some cell types. J. Biol. Chem. 271:24934-38
21. Browning JL, Miatkowski K, Sizing I, Griffiths D, Zafari M, Benjamin CD, Meier W, Mackay F. 1996. Signaling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor lines. J. Exp. Med. 183:867-78
22. Kwon BS, Tan KB, Ni J, Lee KO, Kim KK, Kim YJ, Wang S, Gentz R, Yu GL, Harrop J, Lyn SD, Silverman C, Porter TG, Truneh A, Young PR. 1997. A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J. Biol. Chem. 272:14272-76
23. Rensing Ehl A, Hess S, Ziegler Heitbrock HW, Riethmuller G, Engelmann H. 1995. Fas/Apo-1 activates nuclear factor kappa B and induces interleukin-6 production. J. Inflamm. 45:161-74
24. Kapas L, Hong L, Cady AB, Opp MR, Postlethwaite AE, Seyer JM, Krueger JM. 1992. Somnogenic, pyrogenic, and anorectic activities of tumor necrosis factor-alpha and TNF-alpha fragments. Am. J. Physiol. 263:R708-15
25. Rathjen DA, Ferrante A, Aston R, 1993. Differential effects of small tumour necrosis factor-alpha peptides on tumour cell cytotoxicity, neutrophil activation and endothelial cell procoagulant activity. Immunology 80:293-99
26. Boldin MP, Mett IL, Varfolomeev EE, Chumakov I, Shemer AY, Camonis JH, Wallach D. 1995. Self-association of the "death domains" of the p55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and Fas/APO1 effects. J. Biol. Chem. 270:387-91
27. Naismith JH, Devine TQ, Brandhuber BJ, Sprang SR. 1995. Crystallographic evidence for dimerization of unliganded tumor necrosis factor receptor. J. Biol. Chem. 270:13303-7
28. Hsu H, Shu H-B, Pan M-G, Goeddel DV. 1996. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84:299-308
29. Hsu H, Huang J, Shu H-B, Baichwal V, Goeddel DV. 1996. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4:387-96
30. Takeuchi M, Rothe M, Goeddel DV. 1996. Anatomy of TRAF2. Distinct domains for nuclear factor-κB activation and association with tumor necrosis factor signaling proteins. J. Biol. Chem. 271:19935-42
31. Zhang J, Cado D, Chen A, Kabra NH, Winoto A. 1998. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 392:296-300
32. Force WR, Cheung TC, Ware CF. 1997. Dominant negative mutants of TRAF3 reveal an important role for the coiled coil domains in cell death signaling by the lymphotoxin-beta receptor. J. Biol. Chem. 272:30835-40
33. Declercq W, Denecker G, Fiers W, Vabdenabeele P. 1998. Cooperation of both TNF receptors in inducing apoptosis: involvement of the TNF receptor-associated factor binding domain of the TNF receptor 75. J. Immunol. 161:390-99
34. Weiss T, Grell M, Siemienski K, Mühlenbcck F, Dürkop H, Pfizenmaier K, Scheurich P, Wajant H. 1998. TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TRAF2 and is specific for TNFR60. J. Immunol. 161:3136-42
35. Maskos K, Fernandez-Catalan C, Huber R, Bourenkov GP, Bartunik H, Ellestad GA, Reddy P, Wolfson MF, Rauch CT, Castner BJ, Davis R, Clarke HR, Petersen M, Fitzner JN, Cerretti DP, March CJ, Paxton RJ, A. BR, Bode W. 1998. Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme. Proc. Natl. Acad. Sci. USA 95:3408-12
36. Feinstein E, Wallach D, Boldin M, Varfolomeev E, Kimchi A. 1995. The death domain: a module shared by proteins with diverse cellular functions. Trends Biochem. Sci. 29:342-44
37. Hofmann K, Tschopp J. 1995. The death domain motif found in Fas (Apo-1) and TNF receptor is present in proteins involved in apoptosis and axonal guidance. FEBS Lett. 371:321-23
38. Huang B, Eberstadt M, Olejniczak ET, Meadows RP, Fesik SW. 1996. NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain. Nature 384:638-41
39. Eberstadt M, Huang B, Olejniczak ET, Fesik SW. 1997. The lymphoproliferation mutation in Fas locally unfolds the Fas death domain [letter]. Nat. Struct. Biol. 4:983-85
40. Liepinsh E, Ilag LL, Otting G, Ibanez CF. 1997. NMR structure of the death domain of the p75 neurotrophin receptor. EMBO J. 16:4999-5005
41. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D. 1995. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270:7795-98
42. Chinnalyan AM, O'Rourke K, Tewari M, Dixit VM. 1995. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81:505-12
43. Hsu H, Xiong J, Goeddel DV. 1995. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81:495-504
44. Stanger BZ, Leder P, Lee T-H, Kim E, Seed B. 1995. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81:513-23
45. Duan H, Dixit VM. 1997. RAIDD is a new 'death' adapter molecule. Nature 385:86-89
46. Ahmad M, Srinivasula SM, Wang L, Talanian RV, Litwack G, Fernandes-Alnemri T, Alnemri ES. 1997. CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor-interacting protein RIP. Cancer Res. 57:615-19
47. Yang X, Khosravi Far R, Chang HY, Baltimore D. 1997. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89:1067-76
48. Schievella AR, Chen JH, Graham JR, Lin LL. 1997. MADD, a novel death domain protein that interacts with the type 1 tumor necrosis factor receptor and activates mitogen-activated protein kinase. J. Biol. Chem. 272:12069-75
49. Brown TL, Howe PH. 1998. MADD is highly homologous to a Rab3 guaninenucleotide exchange protein (Rab3-GEP). Curr. Biol. 8:R191
50. Zhang Y, Zhou L, Miller CA. 1998. A splicing variant of a death domain protein that is regulated by a mitogen-activated kinase is a substrate for c-Jun N-terminal kinase in the human central nervous system. Proc. Natl. Acad. Sci. USA 95:2586-91
51. Tartaglia LA, Ayres TM, Wong GH, Goeddel DV. 1993. A novel domain within the 55 kd TNF receptor signals cell death. Cell 74:845-53
52. Adam Klages S, Adam D, Wiegmann K, Struve S, Kolanus W, Schneider Mergener J, Kronke M. 1996. FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell 86:937-47
53. De Vos K, Goossens V, Boone E, Grooten J, Vercammen D, Vancompernolle K, Vandenabeele P, Haegeman G, Fiers W, Grooten J. 1998. The 55-kDa tumor necrosis factor receptor induced clustering of mitochondria through its membrane-proximal region. J. Biol. Chem. 273:9673-80
54. Boldin MP, Mett IL, Wallach D. 1995. A protein related to a proteasomal subunit binds to the intracellular domain of the p55 TNF receptor upstream to its 'death domain'. FEBS Lett. 367:39-44
55. Tsurumi C, Shimizu Y, Saeki M, Kato S, Demartino GN, Slaughter CA, Fujimuro M, Yokosawa H, Yamasaki M, Hendil KB, Toh e A, Tanahashi N, Tanaka K. 1996. cDNA cloning and functional analysis of the p97 subunit of the 26S proteasome, a polypeptide identical to the type-1 tumor-necrosis-factor-receptor-associated protein-2/55.11. Eur. J. Biochem. 239:912-21
56. Song HY, Dunbar JD, Zhang YX, Guo D, Donner DB. 1995. Identification of a protein with homology to hsp90 that binds the type 1 tumor necrosis factor receptor. J. Biol. Chem. 270:3574-81
57. Sato T, Irie S, Kitada S, Reed JC. 1995. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268:411-15
58. Cuppen E, Nagata S, Wieringa B, Hendriks W. 1997. No evidence for involvement of mouse protein-tyrosine phosphatase-BAS-like Fas-associated phosphalase-1 in Fas-mediated apoptosis. J. Biol. Chem. 272:30215-20
59. Rothe M, Wong SC, Henzel WJ, Goeddel DV. 1994. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78:681-92
60. Rothe M, Sarma V, Dixit VM, Gocddel DV. 1995. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science 269:1424-27
61. Nakano H, Oshima H, Chung W, Williams Abbott L, Ware CF, Yagita H, Okumura K. 1996. TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor. J. Biol. Chem. 271:14661-64
62. Marsters SA, Ayres TM, Skubatch M, Gray CL, Rothe M, Ashkenazi A. 1997. Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP-1. J. Biol. Chem. 272: 14029-32
63. Hsu H, Solovyev I, Colombero A, Elliot R, Kelley M, Boyle WJ. 1997. ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5. J. Biol. Chem. 272:13471-74
64. Devergne O, Hatzivassiliou E, Izumi KM, Kaye KM, Kleijnen MF, Kieff E, Mosialos G. 1996. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation. Mol. Cell. Biol. 16:7098-108
65. Wallach D, Boldin MP, Kovalenko AV, Malinin NL, Mett IL, Camonis JH. 1998. The yeast two-hybrid screening technique and its use in the study of protein-protein interactions in apoptosis. Curr. Opin. Immunol. 10:131-36
66. Min W, Bradley JR, Galbraith JJ, Jones SJ, Ledgerwood EC, Pober JS. 1998. The N-terminal domains target TNF receptor-associated factor-2 to the nucleus and display transcriptional regulatory activity. J. Immunol. 161:319-24
67. Darnay BG, Aggarwal BB. 1997. Inhibition of protein tyrosine phosphatases causes phosphorylation of tyrosine-331 in the p60 TNF receptor and inactivates the receptor-associated kinase. FEBS Lett. 410:361-67
68. Beyaert R, Vanhaesebroeck B, Declercq W, Van Lint J, Vandenabele P, Agostinis P, Vandenheede JR, Fiers W. 1995. Casein kinase-1 phosphorylates the p75 tumor necrosis factor receptor and negatively regulates tumor necrosis factor signaling for apoptosis. J. Biol. Chem. 270:23293-99
69. Darnay BG, Singh S, Aggarwal BB. 1997. The p80 TNF receptor-associated kinase (p80TRAK) associates with residues 354-397 of the p80 cytoplasmic domain: similarity to casein kinase. FEBS Lett. 406:101-5
70. Ng PW, Janicke RU, Porter AG. 1998. Mutations which abolish phosphorylation of the TRAF-binding domain of TNF receptor 2 enhance receptor-mediated NF-kappaB activation. Biochem. Biophys. Res. Commun. 244:756-62
71. Pócsik É, Duda E, Wallach D. 1995. Phosphorylation of the 26 kDa TNF precursor in monocytic cells and in transfected HeLa cells. J. Inflamm. 45:152-60
72. Takahashi T, Tanaka M, Inazawa J, Abe T, Suda T, Nagata S. 1994. Human Fas ligand: gene structure, chromosomal location and species specificity. Int. Immunol. 6:1567-74
73. Nicholson DW, Thornberry NA. 1997. Caspases: killer proteases. Trends Biochem. Sci. 22:299-306
74. Boldin MP, Goncharov TM, Goltsev YV, Wallach D. 1996. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO1- and TNF receptor-induced cell death. Cell 85:803-15
75. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM. 1996. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85:817-27
76. Fcrnandes-Alnemri T, Armstrong RC, Krebs J, Srinivasula SM, Wang L, Bullrich F, Fritz LC, Trapani JA, Tomaselli KJ, Litwack G, Alnemri ES. 1996. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc. Natl. Acad. Sci. USA 93:7464-69
77. Vincenz C, Dixit VM. 1997. Fas-associated death domain protein interleukin-1 beta-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, is proximally involved in CD95- and p55-mediated death signaling. J. Biol. Chem. 272:6578-83
78. Wallach D. 1997. Apoptosis. Placing death under control [news; comment]. Nature 388:123,125-26
79. Hofmann K, Bucher P, Tschopp J. 1997. The CARD domain: a new apoptotic signalling motif. Trends Biochem. Sci. 22: 155-56
80. Eberstadt M, Huang B, Chen Z, Meadows RP, Ng SC, Zheng L, Lenardo MJ, Fesik SW. 1998. NMR structure and mutagenesis of the FADD (Mort 1) death-effector domain. Nature 392:941-45
81. Varfolomcev EE, Schuchmann M, Luria V, Chiannilkulchai N, Beckmann JS, Mett IL, Rebrikov D, Brodianski VM, Kemper OC, Kollet O, Lapidot T, Soffer D, Sobe T, Avraham KB, Goncharov T, Holtmann H, Lonai P, Wallach D. 1998. Targeted disruption of the mouse caspase-8 gene ablates cell-death induction by the TNF receptors, Fas/Apo1 and DR3 and is lethal prenatally. Immunity 9:267-76
82. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH, Peter ME. 1997. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 16:2794-804
83. Muzio M, Stockwell BR, Stennicke HR, Salvesen GS, Dixit VM. 1998. An induced proximity model for caspase-8 activation. J. Biol. Chem. 273:2926-30
84. Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Litwack G, Alnemri ES. 1996. Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc. Natl. Acad. Sci. USA 93:14486-91
85. L, and Apaf-1 form a ternary complex. J. Biol. Chem. 273: 5841-45
86. Hirata H, Takahashi A, Kobayashi S, Yonehara S, Sawai H, Okazaki T, Yamamoto K, Sasada M. 1998. Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J. Exp. Med. 187:587-600
87. Stegh AH, Herrmann H, Weisenberger D, Lichter P, Krammer PH, Peter ME. 1998. Identification of the cytoskeletal crosslinker protein plectin as a major in vivo substrate for capsase-8 during CD95-mediated apoptosis. J. Interferon Cytokine Res. 18:A-80 (Abstr.)
88. Luo X, Budihardjo I, Zou Hm Slaughter C, Wang X. 1998. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94:481-90
89. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X. 1997. Cytochrome c and dATP-dependent formation of Apaf-1/Caspase-9 complex initiates and apoptotic protease cascade. Cell 91:479-89
90. Kuwana T,J SJ, Muzio M, Dixit V, Newmeyer DD, Kombluth S. 1998. Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c. J. Biol. Chem. 273:16589-94
91. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin K-M, Krammer PH, Peter ME. 1998. Two CD95 (APO-1/Fas)signaling pathways. EMBO J. 17:1675-87
92. Boise LH, Thompson CB. 1997. Bcl-x(L) can inhibit apoptosis in cells that have undergone Fas-induced protease activation. Proc. Natl. Acad. Sci. USA 94:3759-64
93. Medema JP, Scaffidi C, Krammer PH, Peter ME. 1998. Bcl-xL acts downstream of caspase-8 activation by the CD95 death-inducing signaling complex. J. Biol. Chem. 273:3388-93
94. Srinivasan A, Li F, Wong A, Kodandapani L, Smidt RJ, Krebs JF, Fritz LC, Wu JC, Tomaselli KJ. 1998. Bcl-xL functions downstream of caspase-8 to inhibit Fas- and tumor necrosis factor receptor 1-induced apoptosis of MCF7 breast carcinoma cells. J. Biol. Chem. 273:4523-29
95. Weitzen M, Granger GA. 1980. The human LT system, VIII. A target cell-dependent enzymatic activation step required for the expression of the cytotoxic activity of human lymphotoxin. J. Immunol. 125:719-24
96. 2, which undergoes proteolytic inactivation. J. Biol. Chem. 1998:13870-77
97. Deiss LP, Galinka H, Berissi H, Cohen O, Kimchi A. 1996. Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO J. 15:3861-70
98. Pena LA, Fuks Z, Kolesnick R. 1997. Stress-induced apoptosis and the sphingomyelin pathway. Biochem. Pharmacol. 53:615-21
99. Yeh W, de la Pompa JL, McCurrach ME, Shu H, Elia AJ, Shahinian A, Ng M, Wakeham A, Khoo W, Mitchell K, El-Deiry WS, Lowe SW, Goeddel DV, Mak TW. 1998. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279:1954-58
100. Vercammen D, Beyaert R, Denecker G, Goossens V, Van Loo G, Declercq W, Grooten J, Fiers W, Vandenabeele P. 1998. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J. Exp. Med. 187:1477-85
101. Lemaire C, Andreau K, Souvannavong V, Adam A. 1998. Inhibition of caspase activity induced a switch from apoptosis to necrosis. FEBS Lett. 425:266-270
102. Vercammen D, Brouckaert G, Denecker G, Van de Craen M, Declercq W, Fiers W, Vandenabeele P. 1998. Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J. Exp. Med. 188:919-30
103. Heller RA, Kronke M. 1994. Tumor necrosis factor receptor-mediated signaling pathways. J. Cell. Biol. 126:5-9
104. Hannun YA. 1996. Functions of ceramide in coordinating cellular responses to stress. Science 274:1855-59
105. Zumbansen M, Stoffel W. 1997. Tumor necrosis factor alpha activates NF-kappaB in acid sphingomyelinase-deficient mouse embryonic fibroblasts. J. Biol. Chem. 272:10904-09
106. Wickel M, Heinrich M, Rosenbaum C, Gahr J, Schwandner R, Kreder D, Brunner J, Krönke M, Schütze S. 1998. Identification of cathepsin D as a novel ceramidetarget involved in TNF signaling. J. Interferon Cytokine Res. 18:A-77 (Abstr.)
107. Wiegmann K, Schutze S, Machleidt T, Witte D, Kronke M. 1994. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78:1005-15
108. Cifone MG, Roncaioli P, De Maria R, Camarada G, Santoni A, Ruberti G, Testi R. 1995. Multiple pathways originate at the Fas/APO1 (CD95) receptor: sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. EMBO J. 14:5859-68
109. Kreder D, Schwandner R, Wiegmann K, Adam-Klage S, Schere G, Bernardo K, Pfeffer K, Krönke M. 1998. FAN mediates TNF-dependent activation of neutral sphingomyelinase in vivo. J. Interferon Cytokine Res. 18:A-54 (Abstr.)
110. Schutze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Kronke M. 1992. TNF activates NF-kappaB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71:765-76
111. van den Bosch H, Schalkwijk C, Pfeilschifter J, Marki F. 1992. The induction of cellular group II phospholipase A2 by cytokines and its prevention by dexamethasone. Adv. Exp. Med. Biol. 318:1-10
112. Hoeck WG, Ramesha CS, Chang DJ, Fan N, Heller RA. 1993. Cytoplasmic phospholipase A2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the induced synthesis. Proc. Natl. Acad. Sci. USA 90: 4475-79
113. Lin LL, Wartmann M, Lin AY, Knopf JL, Seth A, Davis RJ. 1993. cPLA2 is phosphorylated and activated by MAP kinase, Cell 72:269-78
114. Kramer RM, Roberts EF, Um SL, Borsch Haubold AG, Watson SP, Fisher MJ, Jakubowski JA. 1996. p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin-stimulated platelets. Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2. J. Biol. Chem. 271: 27723-29
115. 2 by a mitogen-activated protein kinase kinase-dependent mechanism in the human astrocytoma cell line 1321N1. Biochem. J. 328:263-69
116. Wissing D, Mouritzen H, Egeblad M, Poirier GG, Jaattela M. 1997. Involvement of caspase-dependent activation of cytosolic phospholipase A2 in tumor necrosis factor-induced apoptosis. Proc. Natl. Acad. Sci. USA 94:5073-77
117. De Valck D, Beyaert R, Van Roy F, Fiers W. 1993. Tumor necrosis factor cytotoxicity is associated with phospholipase D activation. Eur. J. Biochem. 212:491-97
118. Tepper AD, Cock JG, de Vries E, Borst J, van Blitterswijk WJ. 1997. CD95/Fas-induced ceramide formation proceeds with slow kinetics and is not blocked by caspase-3/CPP32 inhibition. J. Biol. Chem. 272:24308-12
119. Guy GR, Chua SP, Wong NS, Ng SB, Tan YH. 1991. Interleukin 1 and tumor necrosis factor activate common multiple protein kinases in human fibroblasts. J. Biol. Chem. 266:14343-52
120. Wang XY, Kafka M, Dvilansky A, Nathan I. 1996. The roles of protein phosphorylation/dephosphorylation in tumor necrosis factor antitumor effects. J. Interferon Cytokine Res. 16:1021-25
121. Seger R, Krebs EG. 1995. The MAPK signaling cascade. FASEB J. 9:726-35
122. Paul A, Wilson S, Belham CM, Robinson CJ, Scott PH, Gould GW, Plevin R. 1997. Stress-activated protein kinases: activation, regulation and function. Cell Signal. 9:403-10
123. Karin M. 1996. The regulation of AP-1 activity by mitogen-activated protein kinases. Philos. Trans. R. Soc. London B Biol. Sci. 351:127-34
124. Woodgett JR, Kyriakis JM, Avruch J, Zon LI, Zanke B, Templeton DJ. 1996. Reconstitution of novel signalling cascades responding to cellular stresses. Philos. Trans. R. Soc. London B Biol. Sci. 351:135-41
125. Stancovski I, Baltimore D. 1997. NF-kB activation: The IkB kinaserevealed? Cell 91:299-302
126. Verma IM, Stevenson J. 1997. IkappaB kinase: beginning, not the end. Proc. Natl. Acad. Sci. USA 94:11758-60
127. 2-terminal kinase pathway. Science 280: 1945-49
128. Guo YL, Baysal K, Kang B, Yang LJ, Williamson JR. 1998. Correlation between sustained c-Jun N-terminal protein kinase activation and apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells. J. Biol. Chem. 273:4027-34
129. Reinhard C, Shamoon B, Shyamala V, Williams LT. 1997. Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2. EMBO J. 16:1080-92
130. Chen C-M, Zimmerman G, Wu Lee Y-H, Grell M. 1998. Functional analysis of the cytoplasmic region in the lymphotoxin-β receptor (LT-βR). J. Interferon Cytokine Res. 18:A-18(Abstr.)
131. Yeh W, Shahinian A, Speiser D, Kraunus J, Billia F, Wakeham A, de la Pompa J, Ferrick D, Hum B, Iscove N, Ohashi P, Rothe M, Goeddel DV, Mak T. 1997. Early lethality, functional NF-kB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7:715-25
132. Adam D, Ruff A, Strelow A, Wiegmann K, Krönke M. 1998. Induction of stress-activated protein kinase/C-Jun aminoterminal kinases by the p55 tumor nectrosis factor receptor does not require sphingomyelinases. J. Interferon Cytokine Res. 18:A-60 (Abstr.)
133. Rudel T, Bokoch GM. 1997. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 276:1571-74
134. Lee N, MacDonald H, Reinhard C, Halenbeck R, Roulston A, Shi T, Williams LT. 1997. Activation of hPAK65 by caspase cleavage induces some of the morphological and biochemical changes of apoptosis. Proc. Natl. Acad. Sci. USA 94:13642-47
135. Cardone MH, Salvesen GS, Widmann C, Johnson G, Frisch SM. 1997. The regulation of anoikis: MEKK-1 activation requires cleavage by caspases. Cell 90:315-23
136. Deak JC, Cross JV, Lewis M, Qian Y, Parrott LA, Distelhorst CW, Templeton DJ. 1998. Fas-induced proteolytic activation and intracellular redistibution of the stress-signaling kinase MEKK1. Proc. Natl. Acad. Sci. USA 95:5595-600
137. Chan ED, Winston BW, Jarpe MB, Wynes MW, Riches DW. 1997. Preferential activation of the p46 isoform of JNK/SAPK in mouse macrophages by TNF alpha. Proc. Nait. Acad. Sci. USA 94:13169-74
138. Moriguchi T, Toyoshima F, Masuyama N, Hanafusa H, Gotoh Y, Nishida E. 1997. A novel SAPK/JNK kinase, MKK7, stimulated by TNF alpha and cellular stresses. EMBO J. 16:7045-53
139. Toyoshima F, Moriguchi T, Nishida E. 1997. Fas induces cytoplasmic apoptotic responses and activation of the MKK7-JNK/SAPK and MKK6-p38 pathways independent of CPP32-like proteases. J. Cell Biol. 139:1005-15
140. Diener K, Wang XS, Chen C, Meyer CF, Keesler G, Zukowski M, Tan TH, Yao Z. 1997. Activation of the c-Jun N-terminal kinase pathway by a novel protein kinase related to human germinal center kinase. Proc. Natl. Acad. Sci. USA 94:9687-92
141. Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K, Gotoh Y. 1997. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and 38 signaling pathways. Science 275:90-94
142. Cuenda A, Dorow DS. 1998. Differential activation of stress-activated protein kinase SKK4/MKK7 and SKK1/MKK4 by the mixed-lineage kinase-2 and mitogen-activated protein kinase (MKK) kinase-1. Biochem. J. 333:11-15
143. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC. 1995. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:229-33
144. Ridley SH, Sarsfield SJ, Lee JC, Bigg HF, Cawston TE, Taylor DJ, DeWitt DL, Saklatvala J. 1997. Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels. J. Immunol. 158:3165-73
145. Juo P, Kuo CJ, Reynolds SE, Konz RF, Raingeaud J, Davis RJ, Biemann HP, Blenis J. 1997. Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases. Mol. Cell. Biol. 17:24-35. Erratum. 1997. Mol. Cell. Biol. 17:1757
146. Carpentier I, Declercq W, Malinin NL, Wallach D, Fiers W, Beyaert R. 1998. TRAF2 plays a dual role in NF-kappaB-dependent gene activation by mediating the TNF-induced activation of p38 MAPK and IkappaB kinase pathways. FEBS Lett. 425:195-98
147. Winston BW, Chan ED, Johnson GL, Riches DW. 1997. Activation of p38mapk, MKK3, and MKK4 by TNF-alpha in mouse bone marrow-derived macrophages. J. Immunol. 159:4491-97
148. Vietor I, Schwenger P, Li W, Schlessinger J, Vilcek J. 1993. Tumor necrosis factor-induced activation and increased tyrosine phosphorylation of mitogen-activated protein (MAP) kinase in human fibroblasts. J. Biol. Chem. 268:18994-99
149. Van Lint J, Agostinis P, Vandevoorde V, Haegeman G, Fiers W, Merlevede W, Vandenheede JR. 1992. Tumor necrosis factor stimulates multiple serine/threonine protein kinases in Swiss 3T3 and L929 cells. Implication of casein kinase-2 and extracellular signal-regulated kinases in the tumor necrosis factor signal transduction pathway. J. Biol. Chem. 267:25916-21
150. Winston BW, Remigio LK, Riches DW. 1995. Preferential involvement of MEK1 in the tumor necrosis factor-alpha-induced activation of p42mapk/erk2 in mouse macrophages. J. Biol. Chem. 270: 27391-4
151. Yao B, Zhang Y, Delikat S, Mathias S, Basu S, Kolesnick R. 1995. Phosphorylation of Raf by ceramide-activated protein kinase. Nature 378:307-10
152. Kalb A, Bluethmann H, Moore MW, Lesslauer W. 1996. Tumor necrosis factor receptors (Tnfr) in mouse fibroblasts deficient in Tnfr1 or Tnfr2 are signaling competent and activate the mitogen-activated protein kinase pathway with differential kinetics. J. Biol Chem. 271:28097-104
153. Berra E, Diaz Meco MT, Lozano J, Frutos S, Municio MM, Sanchez P, Sanz L, Moscat J. 1995. Evidence for a role of MEK and MAPK during signal transduction by protein kinase C zeta. EMBO J. 14:6157-63
154. Wallach D. 1997. Cell death induction by TNF: a matter of self control. Trends Biochem. Sci. 22:107-46
155. Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M. 1997. Identification and characterization of an IkappaB kinase. Cell 90:373-83
156. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M. 1997. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 386:548-55
157. Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, Young DB, Barbosa M, Mann M, Manning A, Rao A. 1997. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation [see comments]. Science 278:860-66
158. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M. 1997. The IkappaB kinase complex (IKK) contains two kinase suhunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 91:243-52
159. Woronicz JD, Gao X, Cao Z, Rothe M, Goeddel DV. 1997. IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK, Science 278:866-69
160. Lee FS, Hagler J, Chen ZJ, Maniatis T. 1997. Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway. Cell 88:213-22
161. Malinin NL, Boldin MP, Kovalenko AV, Wallach D. 1997. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 385:540-44
162. Ling L, Cao Z, Goeddel DV. 1998. NF-κB-induced kinase activates IKK-α by phosphorylation of Ser-176. Proc. Natl. Acad. Sci. USA 95:3792-97
163. Nakano H, Shindo M, Sakon S, Nishinaka S, Mihara M, Yagita H, Okumura K. 1998. Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1. Proc. Natl. Acad. Sci. USA 95:3537-42
164. Yin MJ, Christerson LB, Yamamoto Y, Kwak YT, Xu S, Mercurio F, Barbosa M, Cobb MH, Gaynor RB. 1998. HTLV-I Tax protein binds to MEKK1 to stimulate IkappaB kinase activity and NF-kappaB activation. Cell 93:875-84
165. Song HY, Regnier CH, Kirschning CJ, Goeddel DV, Rothe M. 1997. Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proc. Natl. Acad. Sci. USA 94:9792-96
166. Natoli G, Costanzo A, Moretti F, Fulco M, Balsano C, Levrero M. 1997. Tumor necrosis factor (TNF) receptor 1 signaling downstream of TNF receptor-associated factor 2. Nuclear factor kappaB (NFkappaB)-inducing kinase requirement for activation of activating protein 1 and NFkappaB but not of c-Jun N-terminal kinase/stress-activated protein kinase. J. Biol. Chem. 272:26079-82
167. Ting AT, Pimentel Muinos FX, Seed B. 1996. RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1 -initiated apoptosis. EMBO J. 15:6189-96
168. Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ, Leder P. 1998. The death domain kinase RIP mediates the TNF-induced NF-kB signal. Immunity 8:297-303
169. Vanden Berghe W, Plaisance S, Boone E, De Bosscher K, Schmitz ML, Fiers W, Hacgeman G. 1998. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. J. Biol. Chem. 273:3285-90
170. Holtmann H, Wallach D. 1987. Down regulation of the receptors for tumor necrosis factor by interleukin 1 and 4 beta-phorbol-12-myristate-13-acetate. J. Immunol. 139:1161-67
171. Mire Sluis A, Meager A. 1994. Tumor necrosis factor (TNF)-induced protein phosphorylation in a human rhabdomyosarcoma cell line is mediated by 60-kD TNF receptors (TR60). Blood 83:2211-20
172. Guesdon F, Knight CG, Rawlinson LM, Saklatvala J. 1997. Dual specificity of the interleukin 1- and tumor necrosis factor-activated beta casein kinase. J. Biol. Chem. 272:30017-24
173. Guo D, Dunbar JD, Yang CH, Pfeffer LM, Donner DB. 1998. Induction of Jak/STAT signaling by activation of the type 1 TNF receptor. J. Immunol. 160:2742-50
174. Wu MY, Hsu TL, Lin WW, Campbell RD, Hsich SL. 1997. Serine/threonine kinase activity associated with the cytoplasmic domain of the lymphotoxin-beta receptor in HepG2 cells. J. Biol. Chem. 272:17154-59
175. Kennedy NJ, Budd RC. 1998. Phosphorylation of FADD/MORT1 and Fas by kinases that associate with the membrane-proximal cytoplasmic domain of Fas. J. Immunol. 160:4881-88
176. Wallach D, Kovalenko AV, Varfolomeev EE, Boldin MP. 1998. Death-inducing functions of ligands of the TNF family: a Sanhedrin verdict. Curr. Opin. Immunol. 10:279-88
177. Madge LA, Sierra-Honigman MR, Pober JS. 1998. Suppression of TNFα-but not IL-1-induced NFκB activation in human endothelial cells by initiation of cell death. J. Interferon Cytokine Res. 18:A71 (Abstr.)
178. Widmann C, Gibson S, Johnson GL. 1998. Caspase-dependent cleavage of signaling proteins during apoptosis: a turn-off mechanism for anti-apoptotic signals. J. Biol. Chem. 273:7141-47
179. Jones S, Prins JB, Savidge J, Ledgerwood EC, Johnson D, Pober JS, Bradley JR. 1998. TNF recruits TRADD to the plasma membrane but not to trans-golgi network, the principal subcellular localization of TNFR1. J. Interferon Cytokine Res. 18:A51 (Abstr.)
180. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. 1998. A caspase-activated DNase that degrades DNA during apoptosis and its inhibitor ICAD. Nature 391:43-50
181. Chandler JM, Cohen GM, MacFarlane M. 1998. Different subcellular distribution of caspase-3 and caspase-7 following Fas-induced apoptosis in mouse liver. J. Biol. Chem. 273:10815-18
182. Mancini M, Nicholson DW, Roy S, Thornberry NA, Peterson EP, Casciola Rosen LA, Rosen A. 1998. The caspase-3 precursor has a cytosolic and mitochondrial distribution: implications for apoptotic signaling. J. Cell Biol. 140:1485-95
183. Ng FW, Nguyen M, Kwan T, Branton PE, Nicholson DW, Cromlish JA, Shore GC. 1997. p28 Bap31, a Bcl-2/Bcl-XL- and procaspase-8-associated protein in the endoplasmic reticulum. J. Cell. Biol. 139:327-38
184. Hill W, Wolf DH. 1996. Proteasomes: destruction as a programme. Trends Biochem. Sci. 21:96-102
185. Rothe M, Pan M-G, Henzel WJ, Ayres TM, Goeddel DV 1995. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83: 1243-52
186. Shu HB, Halpin DR, Goeddel DV. 1997. Casper is a FADD- and caspase-related inducer of apoptosis. Immunity 6:751-63
187. Tartaglia LA, Pennica D, Goeddel DV, 1993. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J. Biol. Chem. 268:18542-48
188. Pinckard JK, Sheehan KC, Schreiber RD, 1997. Ligand-induced formation of p55 and p75 tumor necrosis factor receptor heterocomplexes on intact cells. J. Biol. Chem. 272:10784-89
189. Kalthoff H, Roeder C, Gieseking J, Humburg I, Schmiegel W. 1993. Inverse regulation of human ERBR2 and epidermal growth factor receptors by tumor necrosis factor alpha. Proc. Natl. Acad. Sci. USA 90:8972-76
190. Hudziak RM, Lewis GD, Shalaby MR, Eessalu TE, Aggarwal BB, Ullrich A, Shepard HM. 1988. Amplified expression of the HER2/ERBB2 oncogene induces resistance to tumor necrosis factor alpha in NIH 3T3 cells. Proc. Natl. Acad. Sci. USA 85:5102-6
191. Bird TA, Saklatvata J. 1990. Down-modulation of epidermal growth factor receptor affinity in fibroblasts treated with interleukin 1 or tumor necrosis factor is associated with phosphorylation at a site other than threonine 654. J. Biol. Chem. 265:235-40
192. Perez M, Donato NJ. 1996. Activation of epidermal growth factor receptor tyrosinc phosphorylation by tumor necrosis factor correlates with loss of cytotoxic activity. J. Interferon Cytokine Res. 16:307-14
193. Izumi H, Ono M, Ushiro S, Kohno K, Kung HF, Kuwano M. 1994. Cross talk of tumor necrosis factor-alpha and epidermal growth factor in human microvascular endothelial cells. Exp. Cell. Res. 214:654-62
194. Kanety H, Hemi R, Papa MZ, Karasik A. 1996. Sphingomyelinase and ceramide suppress insulin-induced tyrosine phosphorylation of the insulin receptor substrate-1. J. Biol. Chem. 271:9895-97
195. Peraldi P, Hotamisligil GS, Buurman WA, White MF, Spiegelman BM. 1996. Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J. Biol. Chem. 271:13018-22
196. Aggarwal BB, Moffat B, Harkins RN. 1984. Human lymphotoxin. Production by a lymphoblastoid cell line, purification, and initial characterization. J. Biol. Chem. 259:686-91
197. Gray PW, Aggarwal BB, Benton CV, Bringman TS, Henzel WJ, Jarrett JA, Leung DW, Moffat BNP, Svedersky LP, Palladino MA, Nedwin GE. 1984. Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumor necrosis activity. Nature 312:721-24
198. Aggarwal BB, Kohr WJ, Hass PE, Moffat B, Spencer SA, Henzel WJ, Bringman TS, Nedwin GE, Goeddel DV, Harkins RN. 1985. Human tumor necrosis factor. Production, purification, and characterization. J. Biol. Chem. 260:2345-54
199. Pennica D, Nedwin GE, Hayflick JS, See-burg PH, Derynck R, Paladino MA, Kohr WJ, Aggarwal BB, Goeddel DV. 1984. Human tumor necrosis factor: precursor structure, cDNA cloning, expression, and homology to lymphotoxin. Nature 312:724-29
200. Engelmann H, Novick D, Wallach D. 1990. Two tumor necrosis factor binding proteins purified from human urine. Evidence for immunological cross reactivity with cell surface tumor-necrosis-factor receptors. J. Biol. Chem. 265:1531-36
201. Loctscher H, Schlaeger EJ, Lahm HW, Pan YC, Lesslauer W, Brockhaus M. 1990. Purification and partial amino acid sequence analysis of two distinct tumor necrosis factor receptors from HL60 cells. J. Biol. Chem. 265:20131-38
202. Loetscher H, Pan Y-CE, Lahm H-W, Gentz R, Brockhaus M, Tabuchi H, Lesslauer W. 1990. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 61:351-59
203. Schall TJ, Lewis M, Koller KJ, Lee A, Rice GC, Wong GHW, Gatanaga T, Granger GA, Leutz R, Raab H, Kohr WJ, Goeddel DV. 1990. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61:361-70
204. Smith CA, Davis T, Anderson D, Solam L, Beckmann MP, Jerzy R, Dower SK, Cosman D, Goodwin RG. 1990. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248:1019-23
205. Granger GA, Kolb WP. 1968. Lymphocyte in vitro cytotoxicity: mechanisms of immune and non-immune small lymphocyte mediated target L cell destruction. J. Immunol. 101-.111-20
206. Ruddle NH, Waksman BH. 1968. Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. III. Analysis of mechanisms. J. Exp. Med. 128:1267-79
207. Carswell EA, Old LJ, Kassel S, Green S, Fiore N, Williamson B. 1975. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72:3666-70
208. Yonchara S, Ishii A, Yonehara M. 1989. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen codownregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169:1747-56
209. Trauth BC, Klas C, Peters AM, Matzku S, Moller P, Falk W, Debatin KM, Krammer PH. 1989. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301-5
210. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-43
211. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li WM, Richards S, Dhein J, Trauth BC, Ponstingl H, Krammer PH. 1992. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J. Biol. Chem. 267:10709-15
212. Suda T, Takahashi T, Goldstein P, Nagata S. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169-78
213. Browning JL, Androlewicz MJ, Ware CF. 1991. Lymphotoxin and an associated 33-kDa glycoprotein are expressed on the surface of an activated human T cell hybridoma. J. Immunol. 147:1230-37
214. Baens M, Chaffanet M, Cassiman JJ, van den Berghe H, Marynen P. 1993. Construction and evaluation of a hncDNA library of human 12p transcribed sequences derived from a somatic cell hybrid. Genomics 16:214-18
215. Bazan JF. 1993. Emerging families of cytokines and receptors. Curr. Biol. 3:603-6
216. Engelmann H, Holtmann H, Brakebusch C, Shemer Avni Y, Sarov I, Nophar Y, Hadas E, Leitner O, Wallach D. 1990. Antibodies to a soluble form of a tumor necrosis factor receptor have TNF-like activity. J. Biol. Chem. 265:14497-504
217. Dhein J, Daniel PT, Trauth BC, Oehm A, Moller P, Krammer PH. 1992. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J. Immunol. 149:3166-73
218. Li H, Zhu H, Xu C-J, Yuan J. 1998. Cleavage of BID by caspase 8 mediates the mitochondrial damage. Cell 94:491-501
219. Chang HY, Nishitoh H, Yang X, Ichijo H, Baltimore D. 1998. Activation of Apoptosis Signal-regulating Kinase 1 (ASK1) by the death adaptor Daxx. Science 281:1860-63
220. Nishitoh H, Saitoh M, Mochida Y, Takeda K, Nakano H, Rothe M, Miyazono K, Ichijo H. 1998. ASK1 is essential for JNK/SAPK activation by TRAF2. Mol. Cell 2:1-20
221. Yuasa T, Ohno S, Kehrl JH, Kyriakis JM. 1998. Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK) and p38. Germinal center kinase couples traf2 to mitogen-activated protein kinase/erk kinase kinase 1 and sapk while receptor interacting protein associates with a mitogen-activated protein kinase kinase kinase upstream of mkk6 and p38. J. Biol. Chem. 273:22681-92
222. Shi CS, Kehrl JH. 1997. Activation of stress-activated protein kinase/c-Jun N-terminal kinase, but not NF-kappaB, by the tumor necrosis factor (TNF) receptor 1 through a TNF receptor-associated factor 2- and germinal center kinase related-dependent pathway. J. Biol. Chem. 272:32102-7
223. Shirakabe K, Yamaguchi K, Shibuya H, Irie K, Matsuda S, Moriguchi T, Gotoh Y, Matsumoto K, Nishida E. 1997. TAK1 mediates the ceramide signaling to stress-activated protein kinase/c-Jun N-terminal kinase. J. Biol. Chem. 272:8141-44
224. Schaeffer HJ, Catling AD, Eblen ST, Collier LS, Krauss A, Weber MJ. 1998. MP1: A MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. Science 281:1668-71
225. Whitmarsh AJ, Cavanagh J, Tournier C, Yasuda J, Davis RJ. 1998. A mammalian scaffold complex that selectively mediates MAP kinase activation. Science 281:1671-74